ArticleCell death and differentiation2026
GCN5 and TADA2B constitutively regulate XRCC1 function during DNA repair to maintain cell survival.
Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
XRCC1 orchestrates base excision repair (BER) and single-strand break repair (SSBR) through protein-protein interactions, with disruption contributing to neurological diseases, including spinocerebellar ataxia autosomal recessive 26 (SCAR26). While PARP1-mediated recruitment is well established, constitutive regulatory mechanisms have remained unclear. Here, we identify GCN5 and TADA2B, components of the SAGA histone acetyltransferase complex, as novel XRCC1 binding partners providing constitutive regulation of repair localization. These proteins bind XRCC1 via distinct BRCT domain interactions-GCN5 to BRCT I, TADA2B to BRCT II-independent of DNA damage or GCN5 acetyltransferase activity. Depletion of either protein impairs DNA repair efficiency, sensitizes cells to genotoxic stress, and increases cell death, demonstrating their integral role in cell survival. Unexpectedly, GCN5 or TADA2B deficiency rescues focal retention defects in BRCT II deletion mutants, revealing how constitutive interactions optimize normal XRCC1 function but become counterproductive when XRCC1 is structurally compromised. In addition, the SCAR26-associated BRCT II point mutation disrupts TADA2B binding, yet paradoxically, this normally beneficial interaction becomes inhibitory in the mutant context. Our findings establish a ready-for-action model where repair complexes preorganize machinery before DNA damage occurs, revealing how constitutive regulation determines cellular responses to DNA damage.
Identifiers
42399641What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.